Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kintara Therapeutics Inc (KTRA)

Kintara Therapeutics Inc (KTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,833
  • Shares Outstanding, K 55,305
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,650 K
  • 60-Month Beta 0.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KTRA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.07
  • Most Recent Earnings $-0.05 on 05/14/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1553 +14.49%
on 09/12/24
0.2213 -19.66%
on 10/04/24
+0.0049 (+2.83%)
since 09/11/24
3-Month
0.1553 +14.49%
on 09/12/24
0.2998 -40.69%
on 07/15/24
-0.0956 (-34.97%)
since 07/11/24
52-Week
0.0810 +119.51%
on 03/12/24
4.5861 -96.12%
on 10/19/23
-3.1192 (-94.61%)
since 10/11/23

Most Recent Stories

More News
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives

The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential...

MRK : 109.73 (+0.30%)
NVS : 116.22 (+1.23%)
KTRA : 0.1778 (+0.91%)
RKV.VN : 0.085 (unch)
RHHBY : 39.1800 (+0.80%)
XBIT : 7.45 (+6.89%)
BMRN : 70.35 (+0.72%)
AZN : 77.35 (+0.62%)
Kintara Therapeutics to Present at the LD Micro Main Event XVI Conference

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics to Present at the Emerging Growth Conference

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)
Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

KTRA : 0.1778 (+0.91%)

Business Summary

Kintara Therapeutics Inc. is a biopharmaceutical company. It is focused on the development of new solid tumor cancer therapies. The company's program includes VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer, which are in clinical stage. Kintara Therapeutics Inc. is based in San Diego,...

See More

Key Turning Points

3rd Resistance Point 0.1834
2nd Resistance Point 0.1817
1st Resistance Point 0.1797
Last Price 0.1778
1st Support Level 0.1760
2nd Support Level 0.1743
3rd Support Level 0.1723

See More

52-Week High 4.5861
Fibonacci 61.8% 2.8652
Fibonacci 50% 2.3335
Fibonacci 38.2% 1.8019
Last Price 0.1778
52-Week Low 0.0810

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar